Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases

The response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is largely impacted by the level of virus exposure and status of the host immunity. The nature of protection shown by direct asymptomatic contacts of coronavirus disease 2019 (COVID-19)-positive patients is quite intriguing...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kaushik Sen, Sudeshna Datta, Arup Ghosh, Atimukta Jha, Abdul Ahad, Sanchari Chatterjee, Sandhya Suranjika, Soumya Sengupta, Gargee Bhattacharya, Omprakash Shriwas, Kiran Avula, Jayasingh Kshatri, Punit Prasad, Rajeeb Swain, Ajay K. Parida, Sunil K. Raghav
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/f78d523583884c08bef03f3242ab5395
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f78d523583884c08bef03f3242ab5395
record_format dspace
spelling oai:doaj.org-article:f78d523583884c08bef03f3242ab53952021-12-01T01:47:26ZSingle-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases1664-322410.3389/fimmu.2021.733539https://doaj.org/article/f78d523583884c08bef03f3242ab53952021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fimmu.2021.733539/fullhttps://doaj.org/toc/1664-3224The response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is largely impacted by the level of virus exposure and status of the host immunity. The nature of protection shown by direct asymptomatic contacts of coronavirus disease 2019 (COVID-19)-positive patients is quite intriguing. In this study, we have characterized the antibody titer, SARS-CoV-2 surrogate virus neutralization, cytokine levels, single-cell T-cell receptor (TCR), and B-cell receptor (BCR) profiling in asymptomatic direct contacts, infected cases, and controls. We observed significant increase in antibodies with neutralizing amplitude in asymptomatic contacts along with cytokines such as Eotaxin, granulocyte-colony stimulating factor (G-CSF), interleukin 7 (IL-7), migration inhibitory factor (MIF), and macrophage inflammatory protein-1α (MIP-1α). Upon single-cell RNA (scRNA) sequencing, we explored the dynamics of the adaptive immune response in few representative asymptomatic close contacts and COVID-19-infected patients. We reported direct asymptomatic contacts to have decreased CD4+ naive T cells with concomitant increase in CD4+ memory and CD8+ Temra cells along with expanded clonotypes compared to infected patients. Noticeable proportions of class switched memory B cells were also observed in them. Overall, these findings gave an insight into the nature of protection in asymptomatic contacts.Kaushik SenKaushik SenSudeshna DattaArup GhoshArup GhoshAtimukta JhaAtimukta JhaAbdul AhadAbdul AhadSanchari ChatterjeeSanchari ChatterjeeSandhya SuranjikaSandhya SuranjikaSoumya SenguptaSoumya SenguptaGargee BhattacharyaGargee BhattacharyaOmprakash ShriwasOmprakash ShriwasKiran AvulaKiran AvulaJayasingh KshatriPunit PrasadRajeeb SwainAjay K. ParidaSunil K. RaghavSunil K. RaghavSunil K. RaghavFrontiers Media S.A.articleSARS-CoV-2antibody titerscRNA-seqscBCR-seqscTCR-seqcytokine levelsImmunologic diseases. AllergyRC581-607ENFrontiers in Immunology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic SARS-CoV-2
antibody titer
scRNA-seq
scBCR-seq
scTCR-seq
cytokine levels
Immunologic diseases. Allergy
RC581-607
spellingShingle SARS-CoV-2
antibody titer
scRNA-seq
scBCR-seq
scTCR-seq
cytokine levels
Immunologic diseases. Allergy
RC581-607
Kaushik Sen
Kaushik Sen
Sudeshna Datta
Arup Ghosh
Arup Ghosh
Atimukta Jha
Atimukta Jha
Abdul Ahad
Abdul Ahad
Sanchari Chatterjee
Sanchari Chatterjee
Sandhya Suranjika
Sandhya Suranjika
Soumya Sengupta
Soumya Sengupta
Gargee Bhattacharya
Gargee Bhattacharya
Omprakash Shriwas
Omprakash Shriwas
Kiran Avula
Kiran Avula
Jayasingh Kshatri
Punit Prasad
Rajeeb Swain
Ajay K. Parida
Sunil K. Raghav
Sunil K. Raghav
Sunil K. Raghav
Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases
description The response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is largely impacted by the level of virus exposure and status of the host immunity. The nature of protection shown by direct asymptomatic contacts of coronavirus disease 2019 (COVID-19)-positive patients is quite intriguing. In this study, we have characterized the antibody titer, SARS-CoV-2 surrogate virus neutralization, cytokine levels, single-cell T-cell receptor (TCR), and B-cell receptor (BCR) profiling in asymptomatic direct contacts, infected cases, and controls. We observed significant increase in antibodies with neutralizing amplitude in asymptomatic contacts along with cytokines such as Eotaxin, granulocyte-colony stimulating factor (G-CSF), interleukin 7 (IL-7), migration inhibitory factor (MIF), and macrophage inflammatory protein-1α (MIP-1α). Upon single-cell RNA (scRNA) sequencing, we explored the dynamics of the adaptive immune response in few representative asymptomatic close contacts and COVID-19-infected patients. We reported direct asymptomatic contacts to have decreased CD4+ naive T cells with concomitant increase in CD4+ memory and CD8+ Temra cells along with expanded clonotypes compared to infected patients. Noticeable proportions of class switched memory B cells were also observed in them. Overall, these findings gave an insight into the nature of protection in asymptomatic contacts.
format article
author Kaushik Sen
Kaushik Sen
Sudeshna Datta
Arup Ghosh
Arup Ghosh
Atimukta Jha
Atimukta Jha
Abdul Ahad
Abdul Ahad
Sanchari Chatterjee
Sanchari Chatterjee
Sandhya Suranjika
Sandhya Suranjika
Soumya Sengupta
Soumya Sengupta
Gargee Bhattacharya
Gargee Bhattacharya
Omprakash Shriwas
Omprakash Shriwas
Kiran Avula
Kiran Avula
Jayasingh Kshatri
Punit Prasad
Rajeeb Swain
Ajay K. Parida
Sunil K. Raghav
Sunil K. Raghav
Sunil K. Raghav
author_facet Kaushik Sen
Kaushik Sen
Sudeshna Datta
Arup Ghosh
Arup Ghosh
Atimukta Jha
Atimukta Jha
Abdul Ahad
Abdul Ahad
Sanchari Chatterjee
Sanchari Chatterjee
Sandhya Suranjika
Sandhya Suranjika
Soumya Sengupta
Soumya Sengupta
Gargee Bhattacharya
Gargee Bhattacharya
Omprakash Shriwas
Omprakash Shriwas
Kiran Avula
Kiran Avula
Jayasingh Kshatri
Punit Prasad
Rajeeb Swain
Ajay K. Parida
Sunil K. Raghav
Sunil K. Raghav
Sunil K. Raghav
author_sort Kaushik Sen
title Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases
title_short Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases
title_full Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases
title_fullStr Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases
title_full_unstemmed Single-Cell Immunogenomic Approach Identified SARS-CoV-2 Protective Immune Signatures in Asymptomatic Direct Contacts of COVID-19 Cases
title_sort single-cell immunogenomic approach identified sars-cov-2 protective immune signatures in asymptomatic direct contacts of covid-19 cases
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/f78d523583884c08bef03f3242ab5395
work_keys_str_mv AT kaushiksen singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT kaushiksen singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT sudeshnadatta singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT arupghosh singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT arupghosh singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT atimuktajha singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT atimuktajha singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT abdulahad singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT abdulahad singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT sancharichatterjee singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT sancharichatterjee singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT sandhyasuranjika singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT sandhyasuranjika singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT soumyasengupta singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT soumyasengupta singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT gargeebhattacharya singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT gargeebhattacharya singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT omprakashshriwas singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT omprakashshriwas singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT kiranavula singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT kiranavula singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT jayasinghkshatri singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT punitprasad singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT rajeebswain singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT ajaykparida singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT sunilkraghav singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT sunilkraghav singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
AT sunilkraghav singlecellimmunogenomicapproachidentifiedsarscov2protectiveimmunesignaturesinasymptomaticdirectcontactsofcovid19cases
_version_ 1718405998709833728